Roche cuts 1,000 R&D jobs
June 27, 2012Research and Development, Sales and Marketing AZ, Genentech, Novartis, R&D, Roche, cuts
Roche will make major cuts to its research operations in the US and revamp operations in Europe. Roche will close …
Roche’s Perjeta increases survival
June 27, 2012Research and Development, Sales and Marketing EMA, FDA, Herceptin, Perjeta, Roche, breast cancer
Roche’s new drug Perjeta has scored another trial success by increasing overall survival in certain breast cancer patients. The new …
London Trust on the brink of going bust
June 26, 2012Sales and Marketing Lansley, NHS, South London Healthcare, reforms
For the first time in its history an NHS Trust is facing bankruptcy and could be dissolved by the government. …
Generic approval for Shire’s hyperactivity drug
June 26, 2012Sales and Marketing ADHD, Adderall XR, FDA, IMS Health, Impax, Shire, Teva
US regulators have delivered a blow to Shire by allowing Actavis Group to produce a generic version of its hyperactivity …
Roche earmarks $300m for diagnostics HQ
June 26, 2012Manufacturing and Production Diagnostics, Illumina, Roche, US, manufacturing
Roche has said it intends to invest $300 million over the next 10 years at its diagnostics headquarters in Indianapolis, …
Pharma manufacturing news in brief
June 26, 2012Manufacturing and Production Cook Pharmica, Ubichem Fine Chemicals, Unilife Corp, West Pharmaceutical Services
Unilfe wins a new syringe contract, West Pharma signs a deal with Amgen, plus facility updates from Cook Pharmica and …
FDA looks to start supply chain security programme
June 26, 2012Manufacturing and Production CDER, FDA, OMB, ORA, manufacturing
The FDA has submitted a formal application to start a supply chain security pilot programme for overseas manufacturers of finished …
FDA delays Eliquis approval
June 26, 2012Sales and Marketing BMS, Eliquis, FDA, Pfizer, Xarelto
The FDA has asked Pfizer and Bristol-Myers Squibb for more information about its key blood thinner Eliquis. The US regulator …
Pharma companies share $400m US biosecurity contract
June 26, 2012Manufacturing and Production Emergent BioSolutions, GSK, Novartis, manufacturing
GlaxoSmithKline, Novartis and Emergent BioSolutions will share a $400 million contract from the US government to provide vaccine manufacturing capacity …
FDA rejects licence extension for Xarelto
June 26, 2012Sales and Marketing ACS, Bayer, FDA, J&J, JJ, Pradaxa, Xarelto
The FDA has set a Complete Response Letter to Bayer and J&J over its blood thinner Xarelto. The firms, which …
MPs find NHS bodies still blocking treatments
June 25, 2012Sales and Marketing CCGs, MPs, NHS, NICE, PCTs, Pfizer, viagra
The Labour party has uncovered new restrictions to treatments and drugs in the NHS, which it says is hurting patients …
Steve Bates appointed chief executive of the BioIndustry Association
June 25, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, Genzyme, Steve Bates
The BioIndustry Association (BIA) has appointed Steve Bates as its chief executive. Bates has worked both in biotech and the …
Roche failed to investigate 80,000 safety incidents
June 25, 2012Manufacturing and Production, Sales and Marketing EMA, MHRA, Roche, pharmacovigilance
The European Medicines Agency is investigating Roche after ‘deficiencies’ in the manufacturer’s pharmacovigilance processes came to light. It has emerged …
Pfizer Gaucher drug rejected by CHMP
June 25, 2012Sales and Marketing Elelyso, FDA, Gaucher, Pfizer, Shire, Vpriv
A European committee has refused marketing authorisation for Pfizer’s Gaucher disease drug Elelyso, as a competitor drug has exclusivity to …
The European Medicines Group: focused on UK market access
June 25, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, EMG, NICE, VBP, market access
Maintaining a dialogue with government, NHS organisations and other stakeholder groups is essential for pharma companies in the UK, and …
MP criticises drug shortages
June 25, 2012Sales and Marketing ABPI, Labour, NHS, Whitehead, shortages
A Labour MP has attacked major drug shortages in England that are seeing fewer drugs available to patients in the …
Takeda makes changes to organisation
June 22, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Takeda
Takeda has announced the change of senior leadership and the establishment of a new organisation.Effective from July Masahiro Fujimaki becomes …
Afinitor recommended in Europe for breast cancer
June 22, 2012Sales and Marketing Afinitor, CHMP, Cancer, Novartis, breast
A European committee is recommending Novartis’ Afinitor to treat women with a certain type of breast cancer. The CHMP says …
Pfizer vows to learn from virtual trial failure
June 22, 2012Medical Communications Pfizer, REMOTE, Think science now, digital
Several months after Pfizer failed to recruit patients to its first ever virtual trial, the firm said it was looking …
NHS makes £700m savings from medicines
June 22, 2012Sales and Marketing Conferederation, NHS, QIPP, reforms
The NHS has made £700 million in savings from prescription medicines over the past year. This is according to the …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
